 |
|
|
2008 |
|
|
07/09/08 |
 |
Testimony of Robert Vito, Regional Inspector General for Evaluation and Inspections, Office of Inspector General, U.S. Department of Health and Human Services, before the U.S. Senate Permanent Subcommittee on Investigations, Committee on Homeland Security and Governmental Affairs PDF |
05/15/08 |
|
Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the U.S. House Committee on Energy and Commerce, Subcommittee on Oversight and Investigations, on Nursing Home Quality Issues PDF |
02/27/08 |
|
Testimony of Gregory Demske, Assistant Inspector General for Legal Affairs, before the U.S. Senate Special Committee on Aging Examining the Relationship between the Medical Device Industry and Physicians PDF |
2007 |
|
|
07/18/07 |
|
Statement of Gregory Demske, Assistant Inspector General for Legal Affairs, before the U.S. Senate Special Committee on Aging on the Role of OIG in Identifying and Preventing the Abuse of the Elderly PDF |
06/26/07 |
|
Testimony of Robert A. Vito, Regional Inspector General for Evaluation and Inspections Office of Inspector General, U.S. Department of Health and Human Services, before the House Committee on Ways and Means Subcommittee on Health on ESRD-Related Services PDF |
04/18/07 |
|
Testimony of Stuart Wright, Deputy Inspector General for Evaluation and Inspections, before the Subcommittee on Health of the U.S. House Committee on Energy and Commerce on Medicare Program Efficiency and Integrity PDF |
03/08/07 |
|
Testimony of Daniel R. Levinson, Inspector General, before the U.S. House of Representatives Ways and Means Subcommittees on Health and Oversight on Medicare Program Integrity PDF |
02/09/07 |
|
Testimony of Lewis Morris, Chief Counsel to the Inspector General, before the U.S. House Oversight and Government Reform Committee, on Allegations of Waste, Fraud and Abuse in Pharmaceutical Pricing: Financial Impacts on Federal Health Programs PDF |
2006 |
|
|
07/13/06 |
|
Testimony
of Robert A. Vito, Regional Inspector General for
Evaluation and Inspections, Philadelphia, before
the House Committee on Ways & Means, Subcommittee
on Health, on Medicare Part B Prescription Drug
Reimbursements. PDF |
04/06/06 |
|
Testimony
of Lewis Morris, Chief Counsel to the Inspector
General, before the Subcommittee on Health of the
U.S. House Committee on Ways and Means on issues
regarding health care information technology PDF |
03/28/06 |
|
Testimony
of Daniel R. Levinson, Inspector General, before
the Subcommittee on Federal Financial Management,
Government Information, and International Security
of the Senate Committee on Homeland Security and
Governmental Affairs on Medicaid Program Integrity PDF |
|
2005
|
|
|
12/15/05 |
|
Testimony of Stuart Wright, Deputy Inspector General
for Evaluation and Inspections, before the Subcommittee
on Oversight and Investigations of the U.S. House
Committee on Energy and Commerce on 340B Drug Pricing
Program Oversight and Administration PDF |
10/07/05 |
|
Testimony
of Lewis Morris, Chief Counsel to the Inspector General,
before the Subcommittee on Health of the U.S. House Committee
on Ways and Means on Gainsharing Arrangements PDF |
09/28/05 |
|
Testimony
of Joseph E. Vengrin, Deputy Inspector General for Audit
Services and Michael E. Little, Deputy Inspector General
for Investigations, before the Oversight and Investigations
Subcommittee of the U.S. House Committee on Energy and Commerce
on Guarding Against Waste, Fraud, and Abuse in Post-Katrina
Relief and Recovery PDF |
06/29/05 |
|
Testimony
of Robert A. Vito, Regional Inspector General for Evaluation
and Inspections, Philadelphia, before the U.S. Senate Committee
on Finance on Medicaid Payments for Prescription Drugs PDF |
06/28/05 |
|
Testimony
of Daniel R. Levinson, Inspector General, before the U.S.
Senate Committee on Finance on Medicaid: Federal and State
Oversight PDF |
06/28/05 |
|
Testimony
of George M. Reeb, Assistant Inspector General for CMS
Audits, before the U.S. Senate Committee on Finance on
Medicaid: Financial Mechanisms to Shift Costs to the Federal
Government PDF
|
02/17/05
|
|
Testimony
of Daniel R. Levinson, Acting Inspector General, before the U.S. Senate Committee
on Finance on Confirmation PDF
|
|
2004
|
|
|
|
12/07/04
|
|
Testimony of George
Reeb, Assistant Inspector General for CMS Audits, before the Oversight and
Investigations Subcommittee of the U.S. House Committee on Energy and Commerce
on Medicaid-Covered Drugs and Why the Government Pays Too Much PDF
|
|
06/24/04
|
|
Testimony of Lewis Morris, Chief Counsel to the Inspector General,
before the Oversight and Investigations Subcommittee of the U.S. House Committee
on Energy and Commerce on Discounts Offered to Patients Who Cannot Afford to
Pay Their Hospital Bills PDF |
|
04/28/04
|
|
Testimony of Dara
Corrigan, Acting Principal Deputy Inspector General, before the U.S. Senate
Committee on Finance on Medicare Reimbursement for Power Wheelchairs PDF
|
|
03/18/04
|
|
Testimony of George
Reeb, Assistant Inspector General for CMS Audits, before the House Energy and
Commerce Subcommittee on Health on Intergovernmental Transfers and Accountability
of Medicaid Funds PDF
|
|
2003
|
|
|
|
07/17/03
|
|
Testimony of Dara
Corrigan, Acting Principal Deputy
Inspector General, before the U.S.
Senate Committee on Finance on the
Quality of Care in Nursing Homes
Nationwide PDF
|
|
07/09/03
|
|
Testimony of Dara Corrigan,
Acting Principal Deputy Inspector General,
before the U.S. House of Representatives
Committee on the Budget on Fraud, Waste
and Abuse in the Medicare and Medicaid
Programs PDF
|
|
2002 |
|
|
| 10/03/02 |
|
Testimony
of George Reeb, Assistant Inspector
General, before the House Committee
on Ways and Means, Subcommittee on
Health on Medicare Payments for Currently
Covered Prescription Drugs PDF |
| 07/31/02 |
|
Testimony
of Michael F. Mangano, Principal Deputy
Inspector General, before the Senate
Committee on Governmental Affairs,
Subcommittee on Oversight of Government
Management, Restructuring and the
District of Columbia on consumer safety
and the effectiveness of the Food
and Drug Administration’s (FDA) adverse
event reporting system for dietary
supplements PDF |
| 06/13/02 |
|
Testimony
of Michael F. Mangano, Principal Deputy
Inspector General, before the House
Committee on Government Reform, Subcommittee
on Government Efficiency, Financial
Management and Intergovernmental Relations
on how the Federal Government and
the States protect the Medicaid program
and its beneficiaries against fraud,
waste, and abuse PDF |
| 06/12/02 |
|
Testimony
of Janet Rehnquist, Inspector General,
before the Senate Committee on Appropriations
Subcommittee on Labor, HHS, and Education
on Medicare Reimbursement for Medical
Equipment and Supplies PDF |
| 05/01/02 |
|
Testimony
of Janet Rehnquist, Inspector General,
before the House Energy and Commerce,
Oversight and Investigations Subcommittee
on the "Oversight and Management
of the Government Purchase Card Program" PDF
|
| 03/14/02 |
|
Testimony
of Janet Rehnquist, Inspector General,
before the Senate Committee on Finance
on Medicare: Reimbursement for Prescription
Drugs PDF |
| 03/05/02 |
|
Testimony
of Janet Rehnquist, Inspector General,
before the House Subcommittee on Labor-HHS-Education
Appropriations on the Office of Inspector
General FY 2003 Budget PDF |
| |
|
|
